49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

15 trials found

diseases per page:

Showing 1 to 10 of 15 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04060888 (ClinicalTrials.gov)	July 14, 2020	16/8/2019	A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin C ...	Lupus Erythematosus, Systemic	Drug: Ustekinumab (approximately 6 mg/kg);Drug: Ustekinumab 90 milligram (mg);Drug: Placebo	Janssen Research & Development, LLC	NULL	Withdrawn	18 Years	75 Years	All	0	Phase 3	China
2	EUCTR2017-001489-53-PT (EUCTR)	04/02/2019	08/11/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Ecuador;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Col ...
3	EUCTR2017-001489-53-PL (EUCTR)	24/09/2018	23/07/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
4	JPRN-JapicCTI-183973	16/8/2018	29/05/2018	A Study of Ustekinumab in Participants with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Lupus Erythematosus, Systemic	Intervention name : Ustekinumab INN of the intervention : Ustekinumab Dosage And administration of the ...	Janssen Pharmaceutical K.K.	NULL	complete	16	75	BOTH	500	Phase 3	Japan, Asia except Japan, North America, South America, Europe, Africa
5	EUCTR2017-001489-53-BG (EUCTR)	27/06/2018	28/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
6	EUCTR2017-001489-53-HU (EUCTR)	14/06/2018	03/04/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	Portugal;United States;Serbia;Philippines;Taiwan;Ecuador;Spain;Ukraine;Lithuania;Russian Federation; ...
7	EUCTR2017-001489-53-ES (EUCTR)	12/06/2018	14/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	Portugal;United States;Serbia;Philippines;Taiwan;Ecuador;Spain;Ukraine;Lithuania;Russian Federation; ...
8	EUCTR2017-001489-53-DE (EUCTR)	08/05/2018	23/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
9	EUCTR2017-001489-53-LT (EUCTR)	07/05/2018	19/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
10	NCT03517722 (ClinicalTrials.gov)	April 16, 2018	13/4/2018	A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumabin S ...	Lupus Erythematosus, Systemic	Drug: Placebo;Drug: Ustekinumab (approximately 6 mg/kg);Drug: Ustekinumab 90 mg	Janssen Research & Development, LLC	NULL	Terminated	16 Years	75 Years	All	516	Phase 3	United States;Argentina;Bulgaria;Canada;China;Colombia;Germany;Hungary;Japan;Korea, Republic of;Lith ...

First Previous1 2Next Last